Get the Stockscreener App
1.10
0.92%
+0.01
Societal CDMO Inc stock is currently priced at $1.10, with a 24-hour trading volume of 513.46K.
It has seen a +0.92% increased in the last 24 hours and a +0.92% rose in the past month.
The chart indicates a potential bullish trend, as the stock is above the $1.09 pivot point. If it approaches the $1.10 resistance level, significant changes may occur.
Previous Close:
$1.09
Open:
$1.09
24h Volume:
513.46K
Market Cap:
$121.61M
Revenue:
$94.64M
Net Income/Loss:
$-13.27M
P/E Ratio:
-3.5484
EPS:
-0.31
Net Cash Flow:
$-9.24M
1W Performance:
+0.00%
1M Performance:
+0.92%
6M Performance:
+207.26%
1Y Performance:
+41.03%
1D Range:
$1.09
$1.10
52W Range:
$0.26
$1.28
Societal CDMO Inc Stock (SCTL) Company Profile
Name
Societal CDMO Inc
Sector
Phone
770 534 8239
Address
1 E. Uwchlan Avenue, Suite 112, Exton
Societal CDMO Inc Stock (SCTL) Latest News
CoreRx, Inc. Completes Acquisition of Societal CDMO, Inc.
GlobeNewswire Inc.
S&P 500 Moves Higher; Hayward Holdings Shares Jump On Upbeat Results
Benzinga
Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Benzinga
Crude Oil Moves Higher; Best Buy Posts Upbeat Earnings
Benzinga
Nasdaq Gains 100 Points Following PCE Data
Benzinga
Why Is Biotech/Pharma Contract Service Provider Societal CDMO Stock Trading Higher On Thursday?
Benzinga
Societal CDMO Inc Stock (SCTL) Financials Data
Societal CDMO Inc (SCTL) Revenue 2024
SCTL reported a revenue (TTM) of $94.64 million for the quarter ending December 31, 2023, a +4.90% rise year-over-year.
Societal CDMO Inc (SCTL) Net Income 2024
SCTL net income (TTM) was -$13.27 million for the quarter ending December 31, 2023, a +33.23% increase year-over-year.
Societal CDMO Inc (SCTL) Cash Flow 2024
SCTL recorded a free cash flow (TTM) of -$9.24 million for the quarter ending December 31, 2023, a +22.95% increase year-over-year.
Societal CDMO Inc (SCTL) Earnings per Share 2024
SCTL earnings per share (TTM) was -$0.15 for the quarter ending December 31, 2023, a +57.14% growth year-over-year.
About Societal CDMO Inc
Societal CDMO, Inc., a contract development and manufacturing organization, engages in the development, manufacturing, and packaging for various therapeutic dosage forms primarily in the small molecule therapeutic development in the United States and internationally. It offers its products in the form of oral solid doses, sterile injectables, oral liquids, tablets, topicals, liquid/powder filled capsules, ophthalmic droppers, liposomes, and nano/microparticles, as well as in the areas of aseptic fill/finish, lyophilization, packaging, and logistics services. The company was formerly known as Recro Pharma, Inc. and changed its name to Societal CDMO, Inc. in March 2022. Societal CDMO, Inc. was incorporated in 2007 and is based in Exton, Pennsylvania.
1.69%
1.28%
Cap:
|
Volume (24h):